Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2009 | 1 |
2015 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15.
N Engl J Med. 2023.
PMID: 36920778
Clinical Trial.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group.
Rosmarin D, et al.
N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828.
N Engl J Med. 2022.
PMID: 36260792
Item in Clipboard
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators.
Griffiths CE, et al.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
Lancet. 2015.
PMID: 26072109
Clinical Trial.
Item in Clipboard
Basosquamous carcinoma.
Bowman PH, Ratz JL, Knoepp TG, Barnes CJ, Finley EM.
Bowman PH, et al. Among authors: knoepp tg.
Dermatol Surg. 2003 Aug;29(8):830-2; discussion 833. doi: 10.1046/j.1524-4725.2003.29217.x.
Dermatol Surg. 2003.
PMID: 12859383
Item in Clipboard
DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial.
Eichenfield LF, DuBois JC, Gold MH, Nardo CJ, Draelos ZD; DMT310 Study Group.
Eichenfield LF, et al.
J Am Acad Dermatol. 2023 Nov;89(5):945-951. doi: 10.1016/j.jaad.2023.05.070. Epub 2023 Jun 7.
J Am Acad Dermatol. 2023.
PMID: 37295506
Free article.
Item in Clipboard
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M; Adapalene-BPO Study Group.
Gollnick HP, et al.
Br J Dermatol. 2009 Nov;161(5):1180-9. doi: 10.1111/j.1365-2133.2009.09209.x. Epub 2009 May 21.
Br J Dermatol. 2009.
PMID: 19466959
Clinical Trial.
Item in Clipboard
Cite
Cite